What is NAGE's pharmaceuticals segment — sales, net?

NAGE (NAGE) reported pharmaceuticals segment — sales, net of $0 in Q1 2026.

What does pharmaceuticals segment — sales, net mean?

This metric represents the total revenue generated from the sale of pharmaceutical products within the specified business segment, net of returns, allowances, and discounts. It serves as a primary indicator of the segment's market penetration and commercial success in the healthcare sector. Monitoring this figure helps investors assess the top-line growth trajectory and demand for the company's therapeutic portfolio.

NAGE NAGE Pharmaceuticals segment — Sales, net

Similar metrics at other companies

BAXPharmaceuticals — Net Sales

$621M+6.9%

MIRMProduct sales, net — Product sales, net

$159.88M+43.3%

BCRXProduct sales, net — Total revenues

$151.4M+5.3%

KNSAPharmaceutical — Revenue

$214.27M+55.5%

COLLSegment — Product revenues, net

$193.52M+8.9%

AMP

AMPHPharmaceutical Products — Revenue

$171.17M+0.4%

Other financials

Income statement

See full

Revenue$31.5M+3.3%

Gross profit$20.0M+3.3%

Operating income$1.6M-67.0%

Net income$6.3M+24.8%

EPS (diluted)$0.07+16.7%

Balance sheet

See full

Cash & equivalents$66.5M+19.7%

Total debt$2.6M-26.9%

Total equity$82.3M+48.8%

Total assets$114.3M+40.6%

Cash flow

See full

Operating cash flow-$1.2M-115%

Valuation

See full

Market cap$277.96M-71.6%

Enterprise value$213.99M-76.8%

P/E14.9×-40.3×

P/S2.1×-6.3×

Profitability

See full

Gross margin64.3%+1.8pp

Operating margin10%-2.2pp

Net margin14.3%+1.2pp

FCF margin-70.4%—

Returns & leverage

See full

Return on equity27.1%-6.4pp

Debt / equity0×0.0×

Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's pharmaceuticals segment — sales, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NAGE's pharmaceuticals segment — sales, net?: NAGE (NAGE) reported pharmaceuticals segment — sales, net of $0 in Q1 2026.
What does pharmaceuticals segment — sales, net mean?: This metric represents the total revenue generated from the sale of pharmaceutical products within the specified business segment, net of returns, allowances, and discounts. It serves as a primary indicator of the segment's market penetration and commercial success in the healthcare sector. Monitoring this figure helps investors assess the top-line growth trajectory and demand for the company's therapeutic portfolio.